XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.
Eline BoonsTatiane C NogueiraTim DierckxSoraya Maria MenezesMaarten JacquemynSharon TamirYosef LandesmanLourdes FarréAchiléa BittencourtKeisuke KataokaSeishi OgawaRobert SnoeckGraciela AndreiJohan Van WeyenberghDirk DaelemansPublished in: Blood cancer journal (2021)